Korro Bio raised $91.5 million to run its platform of single-base RNA edits to treat a range of diseases. The Cambridge based biotech will use the cash haul toward getting its preclinical program into the clinic, while also “establishing a…

Baltimore, Maryland-based WellDoc has raised $22 million in a round. Samsung Ventures acted as the lead investor in the round with existing investor Merck Global Health Innovation Fund serving as co-lead. Adage Capital Management, Excel Venture Management, Alexandria Venture Investments…